PatientIQ
PrivateLast Round
Series C
Sep 3, 2026
Est. Valuation
$83M
Total Funding Raised
$57.18M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
PatientIQ operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Series C round in September 2026.
PatientIQ is a healthcare technology company that provides a cloud-based platform for healthcare providers, life sciences organizations, and research institutions to systematically collect, measure, and analyze patient-reported outcomes data.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Healthcare Analytics, Patient Engagement, Clinical Trials, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PatientIQ Comparables
Compare PatientIQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArborMetrix | 83% | |
| OutcomeMD | 82% | |
| OBERD | 82% |
For institutional investors. Book with your work email.
PatientIQ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 3, 2026 | ||||
| Series B | May 12, 2022 | ||||
| Series A | Mar 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PatientIQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Health Enterprise Partners | Series C, Series B |
| August Capital | Series A, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
$30M round led by Hughes & Company
- Mar 3, 2026
Attended the AAOS 2026 event to discuss outcomes data.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 3, 2026
PatientIQ announces in Illinois on Sep 3rd '26 that Travis Hughes, Founder and Managing Partner of Hughes & Company, is set to join its Board of Directors following Hughes & Company's leadership of its Series C funding round.
- integrates_withSep 3, 2026
As of Sep '26, PatientIQ integrates with Athenahealth, Inc. as part of connectivity with more than 50 EHR systems, embedding outcomes measurement into existing clinical workflows for organizations across more than 20 medical specialties.
- receives_financingSep 3, 2026
On Sep 3rd '26 in Illinois, PatientIQ raises $30M in Series C financing led by Hughes & Company, with Health Enterprise Partners and August Capital participating, to expand its patient outcomes intelligence, real-world evidence platform, and patient marketplace.
- integrates_withSep 3, 2026
PatientIQ integrates with Epic Systems Corporation as part of its connections to more than 50 EHR systems, serving organizations across more than 20 medical specialties.
For institutional investors. Book with your work email.
PatientIQ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PatientIQ's valuation, stock price, and market status.
Is PatientIQ a public or private company?
PatientIQ is a private company.
What is the current stock price of PatientIQ?
PatientIQ is a private company, so its shares have no public market price. Caplight tracks PatientIQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PatientIQ worth (valuation)?
PatientIQ's valuation is estimated at $83.0M based on funding round data.
Can I buy PatientIQ stock?
PatientIQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PatientIQ's last funding round?
PatientIQ's most recent funding round was Series C on September 3, 2026.
Who are the main investors in PatientIQ?
Key investors in PatientIQ include Health Enterprise Partners, August Capital.
Will PatientIQ IPO soon?
No public IPO plans have been announced for PatientIQ.
How can I track PatientIQ secondary market activity?
Caplight tracks bids, offers, and trades in PatientIQ's shares on secondary markets.